As of 2024-12-13, the Intrinsic Value of SHL Telemedicine Ltd (SHLTN.SW) is
0.31 CHF. This SHLTN.SW valuation is based on the model Discounted Cash Flows (EBITDA Exit 5Y).
With the current market price of 2.43 CHF, the upside of SHL Telemedicine Ltd is
-87.20%.
The range of the Intrinsic Value is 0.10 - 0.52 CHF
SHLTN.SW Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
(36.68) - (3.94) |
(6.67) |
-374.6% |
| DCF (Growth 10y) |
(1.31) - (4.50) |
(1.58) |
-165.1% |
| DCF (EBITDA 5y) |
0.10 - 0.52 |
0.31 |
-87.2% |
| DCF (EBITDA 10y) |
0.56 - 1.38 |
0.96 |
-60.7% |
| Fair Value |
-2.37 - -2.37 |
-2.37 |
-197.51% |
| P/E |
(8.50) - (11.76) |
(10.24) |
-521.2% |
| EV/EBITDA |
(0.71) - (0.71) |
(0.72) |
-129.6% |
| EPV |
2.54 - 3.80 |
3.17 |
30.5% |
| DDM - Stable |
(9.84) - (103.72) |
(56.78) |
-2436.5% |
| DDM - Multi |
(0.06) - (0.44) |
(0.10) |
-104.0% |
SHLTN.SW Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
39.83 |
| Beta |
0.40 |
| Outstanding shares (mil) |
16.39 |
| Enterprise Value (mil) |
46.00 |
| Market risk premium |
5.10% |
| Cost of Equity |
4.85% |
| Cost of Debt |
5.50% |
| WACC |
4.45% |